DRC1,,2019-06-03 13:33:00,2.84,MEIP whats hoping for a run to 5but no Oh
stockscan,True,2019-06-03 11:29:00,2.955,MEIP ME401 Jun 3 2019 80 overall response rate in patients with relapsed or refractory follicular lymphoma Intermittent dosing schedule demonstrates comparable overall response rates with lower rate of delayed Grade 3 adverse events compared to continuous dosing schedule
stockscan,,2019-06-03 11:25:00,2.94,MEIP investormeipharmacom2019
twalt,True,2019-06-03 10:25:00,2.942,MEIP finally
bf74,True,2019-06-03 09:43:00,2.877,MEIP is it halted Or just no actions
